As­cend takes Bea­con’s man­u­fac­tur­ing as­sets; 89bio’s $135M build in Chi­na

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial news on new builds, col­lab­o­ra­tions, re­calls and more.

As­cend Ad­vanced Ther­a­pies has

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER